Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

David Blood and Al Gore’s Generation Owns 5.1% of Henry Schein, Inc. (HSIC)

David Blood, the former head of Goldman Sachs Asset Management, and former Vice President Al Gore co-founded Generation Investment Management in 2004. The fund recently filed a 13G with the SEC to disclose ownership of 4.4 million shares of Henry Schein, Inc. (NASDAQ:HSIC), an $8.9 billion market cap medical equipment company, or 5.1% of the total shares outstanding. We track quarterly 13F filings from hundreds of hedge funds, including Generation, as part of our work researching investment strategies (we have found, for example, that the most popular small cap stocks among hedge funds earn an average excess return of 18 percentage points per year) and can see from our database that Generation had owned 4.2 million shares of Henry Schein, Inc. (NASDAQ:HSIC) at the end of March. Check out Generation’s stock picks. At that time the stock was its largest holding by market value, so while only a small number of shares have been bought since that time it’s interesting that Generation would add to its largest position.

In the first quarter of 2013, Henry Schein, Inc. (NASDAQ:HSIC)’s revenue grew by 9% versus a year earlier. The animal health business, which accounted for 28% of total sales, was the fastest-growing of the company’s segments and helped make up for only 3% growth in the dental division (the largest of Henry Schein, Inc. (NASDAQ:HSIC)’s segments, at just over half of revenue). With expenses rising as well, however, there was little change in the company’s pretax income after adding back some restructuring charges to the Q1 2012 numbers.

Henry Schein, Inc. (NASDAQ:HSIC)The financial community, however, is quite bullish on Henry Schein, Inc. (NASDAQ:HSIC): at its current valuation, the stock trades at 22 times trailing earnings. Even if the company was holding its margins steady, and therefore growing net income at the same rate as revenue, it would be difficult to call it undervalued at that price; given the fact that costs seem to outpacing sales, to the point that pretax profits have been rising only modestly, the stock does not look like a good value. Wall Street analysts expect little earnings growth at least in the near term, with their forecasts implying a forward P/E of 19. In addition to Generation’s involvement, billionaire Ken Fisher’s Fisher Asset Management reported a position of 590,000 shares in its own 13F (find Fisher’s favorite stocks). D.E. Shaw, a hedge fund managed by billionaire David Shaw, more than doubled its own holdings in Henry Schein, Inc. (NASDAQ:HSIC) to a total of about 320,000 shares (see more stocks D.E. Shaw owned).

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.